Symposium on Deep Brain Stimulation Held in Washington, D.C.
On Tuesday, BIAA Government Affairs Associate Robert Demichelis attended "Brain Pacemakers: A Promising Approach and a New Era of Hope for Neurological and Psychiatric Disorders," a symposium on deep brain stimulation sponsored by The Office on Disability, U.S. Department of Health and Human Services and the Cleveland Clinic Center for Neurological Restoration.
The symposium featured a number of esteemed speakers including Rep. Bill Pascrell, Co-Chair of the Congressional Brain Injury Task Force and Dr. Andrew C. von Eschenbach, Commissioner of the U.S. Food & Drug Administration.
Symposium discussions focused on the emerging applications and preliminary research findings in the use of deep brain stimulation to treat individuals with disabling neurological and psychiatric disorders.
Initially developed for the treatment of movement disorders, deep brain stimulation also has been found to hold great potential for treating various neurological and neuropsychiatric conditions as well.
The symposium specifically explored promising data and emerging research regarding the benefit of deep brain stimulation in the treatment of individuals with movement disorders, epilepsy, psychiatric disorders, and TBI, as well as the translation of such research into treatment therapies.